baber/WOPTO huggingface dataset:
Patent JP-3649785-B2 (JP)
IPC: F23D17/00
Filed: 1995-09-28
Granted: 2005-05-18
Abstract: The burner comprises a swirl generator for the combustion air-stream and fuel injection devices. Inside a first section (200) of the mixing passage (220) downstream of the swirl-generator (100) are transfer passages (201) delivering the current (40) to the downstream portion (20) of the mixing passage. The latter can be tubular, and the number of transfer passages can be the same as that of the dividing bodies in the generator. Downstream of the transfer passages there can be drillings (21) in the mixing passage tube for air injection in the flow and peripheral directions.
Patent JP-2915717-B2 (JP)
IPC: G01M3/20
Filed: 1992-09-25
Granted: 1999-07-05
Abstract: Trace gas leak detector comprising an analysis cell (1), a primary pump (4) whose intake is connected to an input orifice (5) of the detector via a first pipe (6) fitted with a first valve (7), and a secondary pumping unit having its input connected to the said analysis cell (1) and its delivery to the intake of the primary pump (4), characterised in that the primary pump (4) is a so-called dry pump, the said secondary pumping unit comprising two secondary pumps of mechanical type (2, 3) separated from each other by a second valve (8), the secondary pump (3) nearer the said primary dry pump (4), called the second secondary pump (3), comprising at its delivery a dynamic seal stage (18, 20), and in that a second pipe (9) connects the intake of the said second secondary pump (3), downstream of the said second valve (8), to the said first pipe (6), a third valve (10) being arranged on the said first pipe (6), between the delivery of the said second secondary pump (3) and the junction (11) of the second pipe (9) with the first pipe (6), the said third valve (10) being controlled by a pressure sensor (16) placed at the intake of the said second secondary pump (3). 
<IMAGE>
Patent JP-2780738-B2 (JP)
IPC: H01J29/50
Filed: 1995-10-11
Granted: 1998-07-30
Abstract: A color display system (9) includes a cathode-ray tube (10) and self-converging yoke (30) that produces an astigmatic magnetic deflection field within the tube. The gun (26) includes beam-forming region electrodes (34,36,38,40), main focusing lens electrodes (44,46), and two electrodes (42,44) for forming a multipole lens between the beam-forming region and the main focusing lens in each of the electron beam paths. Each multipole lens is oriented to provide a correction to an associated electron beam to at least partially compensate for the effect of the astigmatic magnetic deflection field on that beam. A first multipole lens electrode (42) is located between the beam-forming region electrodes and the main focusing lens electrodes. A second multipole electrode (44) is connected to a main focusing lens electrode and located between the first multipole lens electrode and the main focusing lens, adjacent to the first multipole lens electrode.
Patent JP-3167068-B2 (JP)
IPC: C09D11/00
Filed: 1993-10-27
Granted: 2001-05-14
Abstract: Disclosed herein is an ink-jet printing method by ejecting an ink from an orifice of a printing head in accordance with a printing signal to conduct printing on a printing material, comprising using an ink having a pH value (pHA) at which the absorbance of the ink becomes a half of the absorbance at the pH in the stable region of the ink on an absorbance curve according to a pH change and a printing material comprising a base material and a coating layer provided thereon having a surface pH value of pHB, and said pHA and pHB satisfying the relationship    pHA < pHB. <IMAGE>
Patent JP-2877253-B2 (JP)
IPC: C07K14/62
Filed: 1989-11-02
Granted: 1999-03-31
Abstract: Polypeptides or proteins such as, for example, insulins or de-B<3><0>-insulins - especially human insulin or de-B<3><0>-human insulin - are prepared by enzymatic cleavage, using a trypsin-like endopeptidase, of specific fusion proteins which can be obtained by genetic manipulation and which contain the residue of a peptide-like alpha -amylase inhibitor in the molecule. The use of the specific fusion proteins results in a reaction product which can be worked up advantageously; the working-up can take place, where appropriate, by crystallisation.
Patent JP-3057374-B2 (JP)
IPC: A61L17/10
Filed: 1990-11-02
Granted: 2000-06-26
Abstract: The present invention relates to novel copolymers made from trimethylene carbonate and optically inactive lactides, to their preparation and to their use.
Patent JP-H0513962-B2 (JP)
IPC: B29C45/00
Filed: 1986-12-16
Abstract: Mixtures of aromatic diamines, polyurethanes made therefrom, and processes for the preparation of the polyurethanes. The mixtures of aromatic diamines of the invention comprise a first aromatic diamine having machine gel time of 1 to 4 seconds in a 50,000 psi modulus RIM formulation reaction and the second aromatic diamine having a slower machine gel time of 1.5 to 15 times that of the first aromatic diamine. The mixtures provide gel times of 2.5 to10 seconds, suitable for filling large molds such as automative body panels. The novel aromatic diamine mixtures allow use of large proportions of diamine to provide polyurethanes which are rigid but not brittle at demold and have unexpectedly superior flexural modulus properties. The polyurethanes formed with the chain extender mixtures of the invention have flexural modulus superior to polyurethanes formed from either of the diamines individually.
Patent JP-H0413814-B2 (JP)
IPC: H01J43/14
Filed: 1986-12-20
Abstract: Electron multiplier tube, comprising along the principal axis an electron-emitting surface, several dynode stages with distributed structure, capable of reflux secondary electron emission, and an electron-receiving surface, as well as means producing an electron-accelerating electric field generally oriented along the principal axis, from the electron-emitting surface to the electron-receiving surface. With it is associated coil means producing a magnetic field generally oriented along the principal axis of the tube. Particular example is a photomultiplier with high spatial resolution.
Patent JP-3299321-B2 (JP)
IPC: C07D407/12
Filed: 1992-10-28
Granted: 2002-07-08
Abstract: Aminomethylchromans are obtained by alkylation of correspondingly substituted amines or by reductive amination of correspondingly substituted aldehydes. The aminomethylchromans can be used as active ingredients in medicaments, in particular for the treatment of disorders of the central nervous system. <IMAGE>
Patent JP-3314740-B2 (JP)
IPC: H02B5/00
Filed: 1998-11-26
Granted: 2002-08-12
Abstract: PROBLEM TO BE SOLVED: To require only one carriage to mount a disconnector by storing the body of the disconnector in a frame, when the disconnector is moved and installing the disconnector body on an upper face of the frame when the disconnector is operated. SOLUTION: A mobile disconnector is provided with a disconnector body 1, a pedestal 21 whereon parts for three phases of the disconnector body 1 are mounted collectivedly, a frame for storing the main body of the disconnector and the pedestal 21, a support member 10 which is bridged over an upper face of a frame 11 and can be moved in the interphase or the interpole direction of the disconnector body 1, and a movable carriage 14 which is mounted with the frame 11. When the disconnector is moved, the support member 10 is located on the edge of the frame 11, and the disconnector body 1 and the pedestal 21 are stored in the frame 11. When the disconnector is operated, the support member 10 is located inside the frame 11 to allow the pedestal 21 to be mounted on the support member 10, thereby allowing the disconnector body 1 to be installed on the frame 11.
Patent JP-2833948-B2 (JP)
IPC: A61P3/06
Filed: 1992-12-25
Granted: 1998-12-09
Abstract: Compounds of formula (I): <CHEM> (in which: R<1> is alkyl; R<2> and R<3> are each alkyl or alkoxy, or R<2> and R<3> together form an optionally substituted benzene ring and, when R<2> and R<3> together form said benzene ring, R<1> is hydrogen, halogen or alkyl; R<4> and R<5> are both hydrogen, or together represent a single carbon-carbon bond; W is a single bond or alkylene; and Z is hydrogen or a cation) have valuable therapeutic and prophylactic activities, including anti-diabetic activities.
Patent JP-H0776229-B2 (JP)
IPC: A23K20/195
Filed: 1990-12-11
Abstract: Gamma lolactone platinum complexes of formula (I) are new: R1 = 1-5C hydrocarbyl; R2,R3 = H or 1-3C hydrocarbyl; and the configuration of the 1,2-diaminocyclohexane ring is cis, trans-l or trans-d.
Patent JP-H0738602-B2 (JP)
IPC: H04B3/23
Filed: 1984-05-25
Abstract: PCT No. PCT/FR84/00140 Sec. 371 Date Jan. 28, 1985 Sec. 102(e) Date Jan. 28, 1985 PCT Filed May 25, 1984 PCT Pub. No. WO84/04858 PCT Pub. Date Dec. 6, 1984.An adaptive echo suppressor is provided at each local station in a data transmission system for transmission of local data from a local station to a remote station over a transmission medium exhibiting an echo and simultaneous transmission of far end data over said medium from said remote station. The echo suppressor comprises an adaptive echo suppressor located at said local station and comprising: an adaptive digital filter connected to receive the local data ax and a clean signal ek substantially free of echo and arranged to deliver on an output an estimation ok of the echo of the local data by multiplying a vector of coefficients Ck with the local data ak, said vector having an adaptation algorithm: Ck+1=Ck+ mu ak*xf(ek) wherein  mu  is a predetermined incrementation step, ak* is a conjugated value of the local data ak, and f is a predetermined function of ek and substractor means having an input connected to receive said far end data signal from said transmission medium, said far end data signal including said far end data and the echo of the local data and a subtractive input connected to receive said estimation ok from said digital filter. The digital filter is rendered only responsive to that vectorial component of ek which is orthogonal to the remote data signal.
Patent JP-2810230-B2 (JP)
IPC: A61K47/48
Filed: 1990-12-04
Granted: 1998-10-15
Abstract: A chimeric antibody-agent conjugate for targeting foci of leukocyte accretion comprises a recombinant chimera having an antigen-binding hypervariable region which binds specifically to granulocytes, and a constant region of a human immunoglobulin having an Fc portion with high affinity for receptors on human mononuclear lymphoid cells, said chimera being conjugated to at least one diagnostic agent or therapeutic agent. A method for targeting an imaging or therapy agent to an inflammatory or infectious lesion comprises injecting a mammal parenterally with an effective amount for targeting of the above chimeric anti-leukocyte conjugate.
Patent JP-H0542967-B2 (JP)
Inventor: PAAKU JUN OKU
IPC: C08G77/38
Filed: 1989-03-22
Abstract: PCT No. PCT/KR89/00006 Sec. 371 Date Nov. 20, 1989 Sec. 102(e) Date Nov. 20, 1989 PCT Filed Mar. 22, 1989 PCT Pub. No. WO89/09240 PCT Pub. Date Oct. 5, 1989.A polysiloxane containing terminal imide groups and process for the preparation thereof by a Michael addition reaction comprising reacting a bismaleimide with a polysiloxane diamine. The imide group-containing polysiloxane has good compatibility with organic resins.
Patent JP-2909206-B2 (JP)
IPC: B29C48/09
Filed: 1990-03-15
Granted: 1999-06-23
Abstract: The invention relates to a process for the production of plastic parts, particularly pipes and sleeves, by the extrusion of a mixture of polyethylene homopolymer, copolymer or block polymer (PE) and a polymeric plasticizer reactive therewith, as well as small amounts of conventional additives, in which the moulded or extruded plastic part optionally subsequently undergoes cross-linking and stretching, or cross-linking only, in which a mixture of PE and EPDM with an average molecular weight of 1,000 to 20,000 in a weight ratio of 90 to 97% PE and 3 to 10% by weight EPDM is moulded or extruded.
Patent JP-H0751514-B2 (JP)
IPC: A61K39/44
Filed: 1986-10-16
Abstract: The invention relates to a process for preparing an immunogenic complex comprising a carrier molecule prepared by mixing viruses, mycoplasmas, bacterias, animal cells or proteins or peptides having hydrophobic regions with one or more solubilizing agents, whereby a complex having been formed between proteins or peptides and solubilizing agents, whereafter the proteins or the peptides have been separated from the solubilizing agent in the presence of a glycoside solution which contains one or more glycosides having hydrophobic and hydrophilic regions in a concentration of at least the critical micellular concentration, or alternatively have been separated from the solubilizing agent and transferred directly to the aforementioned glycoside solution, and the carrier molecule being bound to one or more molecules selected from peptides, proteins, carbohydrates, lipoproteins, glycolipides or small molecules, such as biotine, by coupling with known methods between functional coupling groups in the bound molecules and functional groups in the peptides or the proteins in the carrier molecule. 
<??>The invention also relates to a method for preparing such immunogenic complexes, compositions, vaccines containing such complexes and to reagents.
Patent JP-3317966-B2 (JP)
IPC: H03G9/00
Filed: 1990-04-03
Granted: 2002-08-26
Abstract: Three related embodiments of audio signal dynamic range circuits for consumer and semi-professional audio signal compressors, expanders, and compressor/expander noise reduction systems incorporate certain basic features of professional Spectral Recording (SR) while adapting SR for use with consumer recording media (particularly audio cassette tape) and reducing the cost and complexity of the SR circuitry. In addition, the three embodiments, and particularly the preferred embodiment, provide substantial compatibility with the existing B-type and C-type consumer and semi-professional noise reduction systems. Subjective performance substantially equivalent to 16-bit PCM audio systems is achieved with analog audio cassette tape media. In all three embodiments there are two cascaded stages: (1) a high-level stage a high-frequency fixed-band/sliding band action-substitution sub-stage (324A) and a low-frequency fixed-band sub-stage (328A) and (2) a low-level stage having only a high-frequency fixed-band/sliding band action-substitution sub-stage (326A). The dynamic action regions of the high-frequency action-substitution sub-stages are staggered. Each of the high-frequency sub-stages provides up to 12 dB of dynamic action (together providing up to 24 dB of dynamic action) and operates in a frequency band defined by a single-pole filter having a high-pass shelving response with a corner frequency of 400 Hz. The low-frequency sub-stage provides up to 10 dB of dynamic action and operates in a frequency band defined buy a single-pole filter having a low-pass shelving response with a corner frequency of 200 Hz. The single-pole filter characterisctics provide a broad and smooth overlap of the high-frequency and low-frequency characteristics. Particular forms of spectral skewing and antisaturation enhance the performance of the circuits with consumer recording media.
Patent JP-3155274-B2 (JP)
IPC: C08G59/32
Filed: 1991-03-14
Granted: 2001-04-09
Abstract: Copolymers are produced when 3,4-epoxy-1-butene (EpB) is coplymerized with maleic anhydride. The copolymerization is initiated by free radicals, and comprises both 1,2-propagation and 1,5-propagation of EpB. When an ether is used as the reaction solvent, the product is soluble, and essentially composed of (a) a monomer derived from maleic anhydride, and (b) two monomers derived from EpB. When the reaction solvent is a ketone, the polymer product is also soluble, and additionally contains (c) a moiety derived from a dioxolane formed in situ. When the reaction is conducted in the presence of a non polar (e.g., hydrocarbon or a halocarbon) solvent, or neat (i.e., in the absence of a solvent), the polymer product is insoluble in common organic solvents and contains (d) a symmetrical EpB dimer. This dimer apparently does not form, or is formed to only a very slight extent, when the polymerization is conducted in polar reaction solvents. Polymer products with a dioxolane moiety can be made by using preformed dioxolane in the polymerization mixture. Thus, this invention is not limited to in situ preparation of the dioxolane from a reaction mixture containing a ketone. Products of this invention can be cast as clear films and can also be used as reactive polymers.
Patent JP-H07103290-B2 (JP)
IPC: C08G18/62
Filed: 1989-08-11
Abstract: The invention concerns a curable composition containing A) compounds with at least two activated double bonds (I) based on  alpha , beta -unsaturated carbonyl compounds,  alpha , beta -unsaturated carboxylic esters or  alpha , beta -unsaturated nitrile groups; B) compounds containing either at least one primary amino group blocked by an aldehyde or ketone with not more than 10 carbon atoms or at least two groups which can be hydrolysed to NH groups; and C) ordinary additives, possibly catalysts, possibly pigments and organic solvents. Component A or component B or component A and B are based on a branched, soluble acrylate copolymerizate P which can be obtained by copolymerization of a) 5 to 30 wt.% of monomers with at least ethylenically unsaturated polymerizable double bonds, b) 5 to 60 wt.% of momomers with one functional group and c) 5 to 90 wt.% of other ethylenically unsaturated monomers, the sum of a), b) and c) being equal to 100 wt.%. The invention also concerns methods for preparing the curable composition and its use.
Patent JP-3485184-B2 (JP)
IPC: A61P31/04
Filed: 1990-07-16
Granted: 2004-01-13
Abstract: This invention pertains to interleukins-containing vaccine compositions, comprising a mixture of antigen and an adjuvant amount of an interleukin adsorbed onto a mineral in suspension and a preservative. Preferably, the mineral is alum. The interleukin can modulate the protective immune response to an antigen, while the mineral stabilizes the biological activity of the interleukin.
Patent JP-3152660-B2 (JP)
IPC: G01G19/44
Filed: 1994-01-27
Granted: 2001-04-03
Abstract: PCT No. PCT/FR94/00099 Sec. 371 Date Oct. 10, 1995 Sec. 102(e) Date Oct. 10, 1995 PCT Filed Jan. 27, 1994 PCT Pub. No. WO94/17376 PCT Pub. Date Aug. 4, 1994Apparatus for weighing a person that is confined to a bed that includes a series of modular units for supporting a bed frame and sensors associated with each of the modular units that are capable of performing in combination a weighing function.
Patent JP-3848365-B2 (JP)
IPC: A61N1/30
Filed: 1995-11-27
Granted: 2006-11-22
Abstract: An electrotransport delivery device (410) includes control circuitry for discontinuously delivering a beneficial agent (eg, a drug) through a body surface (eg, skin 400). For example, the device may be the type which is manually activated by the patient or other medical personnel to activate electrotransport drug delivery. Once electrotransport delivery has been activated, a timer (221) counts a transition interval, typically about one minute, during which the device is allowed to operate and the impedance of the body surface (400) is allowed to stabilize. Thereafter, the electrotransport current and voltage are then monitored and compared to predetermined limits. Allowing for the transition interval permits tighter tolerances in monitoring the applied current.
Patent JP-3364224-B2 (JP)
IPC: B01D61/42
Filed: 1994-02-21
Granted: 2003-01-08
Abstract: PCT No. PCT/BE94/00014 Sec. 371 Date May 13, 1996 Sec. 102(e) Date May 13, 1996 PCT Filed Feb. 21, 1994 PCT Pub. No. WO94/19399 PCT Pub. Date Sep. 1, 1995A single-film membrane including at least one hydrophilic interface for breaking water down into is components, and including one or more inorganic compounds. A method for preparing and using the membrane for producing acids and bases, controlling pH and/or electodialyzing and aquous solution, is also provided.
Patent JP-4137996-B2 (JP)
IPC: C12N15/09
Filed: 1993-04-29
Granted: 2008-08-20
Abstract: A method, composition and kit for amplifying a target nucleic acid sequence under conditions of substantially constant temperature, ionic strength, and pH and using only a single promoter-primer. To effect the amplification, a supply of a single promoter-primer having a promoter and a primer complementary to the 3'-end of the target sequence, and a reverse transcriptase and an RNA polymerase are provided to a mixture including the target sequence; the amplification proceeds accordingly. The invention is useful for generating copies of a nucleic acid target sequence for purposes that include assays to quantitate specific nucleic acid sequences in clinical, environmental, forensic and similar samples, cloning and generating probes.
Patent JP-3867998-B2 (JP)
IPC: F04D25/08
Filed: 1996-12-05
Granted: 2007-01-17
Abstract: This invention relates to a process which comprises reacting one or more reactants in the presence of a metal-organophosphite ligand complex catalyst and dissolved water and optionally free organophosphite ligand to produce a reaction product fluid comprising one or more products, wherein said process is conducted in the presence of carbon dioxide in an amount sufficient not to effect substantial degradation of any said organophosphite ligand and/or substantial deactivation of said metal-organophosphite ligand complex catalyst.
Patent JP-3967379-B2 (JP)
IPC: G11B20/14
Filed: 1996-04-01
Granted: 2007-08-29
Abstract: A digital video disk stores data codes and multifunctional synchronization codes in a data structure. The synchronization codes contain type information code identifying whether the synchronization code is located in a code sequence at the beginning of the data block, the beginning of a data block sector other than the first sector in the data block, the beginning of a line, or the middle of a line. The type information is expressed by two alternative patterns, type information code 1 and type information code 2, expressing the same information and differing in the number of is in the 5-bit sequence, i.e., an odd or even number of 1s. Which one of the two type information code pattern is used is selected according to the DSV so as to minimize bias in the dc component of the frame following the synchronization code.
Patent JP-3365512-B2 (JP)
IPC: F27D25/00
Filed: 1998-01-14
Granted: 2003-01-14
Abstract: A device, system and method permitting on-line explosives-based cleaning and deslagging of a fuel burning facility (31) such as a boiler, furnace, incinerator, or scrubber. A coolant, such as ordinary water, is delivered to the explosives (101) to prevent them from detonating due to the heat of the on-line facility. Thus, controlled, appropriately-timed detonation can be initiated as desired, and boiler scale and slag is removed without the need to shut down or cool down the facility.
Patent JP-4339408-B2 (JP)
IPC: B29D30/52
Filed: 1998-02-05
Granted: 2009-10-07
Abstract: A tread for a tire, the tread being provided with a plurality of cutouts, defined by walls perpendicular to or oblique to the rolling surface of the tread, in which the two main walls of at least one cutout located in the part of the tread affected by the loading on the ground of the tire during travel are connected by at least one rubber connecting element and in that the total connection surface SE of the connecting element(s) is at most 80% of the surface defined by the geometric contour L of minimum length and surrounding said total connection surface SE. A method for producing a cutout provided with at least one connecting element.